JSPR insider buying and SEC filings, explained
Jasper Therapeutics, Inc. · CIK 1788028
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$0
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Jul 20, 2026 | Other purchase | Matthew E Ros (President / COO) bought 881 shares; the filing does not report a price. New position of 881 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 22, 2026 |
| Jul 20, 2026 | Other purchase | Patrick J Crutcher (Director) bought 888 shares; the filing does not report a price. New position of 888 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 20, 2026 |
10 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow JSPR in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.